全文获取类型
收费全文 | 1253436篇 |
免费 | 96390篇 |
国内免费 | 1555篇 |
专业分类
耳鼻咽喉 | 16295篇 |
儿科学 | 40849篇 |
妇产科学 | 34940篇 |
基础医学 | 187741篇 |
口腔科学 | 34696篇 |
临床医学 | 117029篇 |
内科学 | 245079篇 |
皮肤病学 | 27257篇 |
神经病学 | 101026篇 |
特种医学 | 46715篇 |
外国民族医学 | 265篇 |
外科学 | 177931篇 |
综合类 | 25696篇 |
现状与发展 | 3篇 |
一般理论 | 568篇 |
预防医学 | 103760篇 |
眼科学 | 27974篇 |
药学 | 92219篇 |
6篇 | |
中国医学 | 1951篇 |
肿瘤学 | 69381篇 |
出版年
2018年 | 13529篇 |
2017年 | 10390篇 |
2016年 | 11321篇 |
2015年 | 13079篇 |
2014年 | 18001篇 |
2013年 | 27478篇 |
2012年 | 37576篇 |
2011年 | 39969篇 |
2010年 | 23054篇 |
2009年 | 22256篇 |
2008年 | 37752篇 |
2007年 | 40383篇 |
2006年 | 39963篇 |
2005年 | 39098篇 |
2004年 | 37543篇 |
2003年 | 35841篇 |
2002年 | 34763篇 |
2001年 | 55891篇 |
2000年 | 56865篇 |
1999年 | 47723篇 |
1998年 | 12442篇 |
1997年 | 11302篇 |
1996年 | 11705篇 |
1995年 | 11812篇 |
1994年 | 11023篇 |
1993年 | 10313篇 |
1992年 | 38126篇 |
1991年 | 37656篇 |
1990年 | 36419篇 |
1989年 | 35240篇 |
1988年 | 32649篇 |
1987年 | 32005篇 |
1986年 | 30496篇 |
1985年 | 28761篇 |
1984年 | 21901篇 |
1983年 | 19127篇 |
1982年 | 11302篇 |
1981年 | 10255篇 |
1979年 | 20878篇 |
1978年 | 15355篇 |
1977年 | 12719篇 |
1976年 | 11780篇 |
1975年 | 12772篇 |
1974年 | 15550篇 |
1973年 | 15323篇 |
1972年 | 14497篇 |
1971年 | 13539篇 |
1970年 | 12758篇 |
1969年 | 12048篇 |
1968年 | 11214篇 |
排序方式: 共有10000条查询结果,搜索用时 23 毫秒
51.
52.
53.
Sine Wichmann Martin Schønemann-Lund Anders Perner Theis S. Itenov Theis Lange Christian Gluud Rasmus E. Berthelsen Anne C. Brøchner Jørgen Wiis Morten H. Bestle 《Acta anaesthesiologica Scandinavica》2023,67(4):470-478
Background
Salt and water accumulation leading to fluid overload is associated with increased mortality in intensive care unit (ICU) patients, but diuretics' effects on patient outcomes are uncertain. In this first version of the GODIF trial, we aimed to assess the effects of goal-directed fluid removal with furosemide versus placebo in adult ICU patients with fluid overload.Methods
We conducted a multicentre, randomised, stratified, parallel-group, blinded, placebo-controlled trial in clinically stable, adult ICU patients with at least 5% fluid overload. Participants were randomised to furosemide versus placebo infusion aiming at achieving neutral cumulative fluid balance as soon as possible. The primary outcome was the number of days alive and out of the hospital at 90 days.Results
The trial was terminated after the enrolment of 41 of 1000 participants because clinicians had difficulties using cumulative fluid balance as the only estimate of fluid status (32% of participants had their initially registered cumulative fluid balance adjusted and 29% experienced one or more protocol violations). The baseline cumulative fluid balance was 6956 ml in the furosemide group and 6036 ml in the placebo group; on day three, the cumulative fluid balances were 1927 ml and 5139 ml. The median number of days alive and out of hospital at day 90 was 50 days in the furosemide group versus 45 days in the placebo group (mean difference 1 day, 95% CI -19 to 21, p-value .94).Conclusions
The use of cumulative fluid balance as the only estimate of fluid status appeared too difficult to use in clinical practice. We were unable to provide precise estimates for any outcomes as only 4.1% of the planned sample size was randomised. 相似文献54.
Janitz Amanda E. Schraw Jeremy M. Xu Chao Lupo Philip J. 《Cancer causes & control : CCC》2022,33(3):483-488
Cancer Causes & Control - Congenital malformations are strong risk factors for childhood cancer. Our objective was to determine whether cancer survival differs by birth defect status among... 相似文献
55.
56.
Philip J. Lupo Ruth E. Luna-Gierke Tiffany M. Chambers Björn Tavelin Michael E. Scheurer Beatrice Melin Karin Papworth 《International journal of cancer. Journal international du cancer》2020,146(3):791-802
Perinatal factors have been associated with soft tissue sarcomas (STS) in case-control studies. However, (i) the contributions of factors including fetal growth remain unknown, ( ii ) these factors have not been examined in cohort studies and (iii) few assessments have evaluated risk in specific STS subtypes. We sought to identify the role of perinatal and familial factors on the risk of STS in a large population-based birth cohort. We identified 4,023,436 individuals in the Swedish Birth Registry born during 1973–2012. Subjects were linked to the Swedish Cancer Registry, where incident STS cases were identified. We evaluated perinatal and familial factors obtained from Statistics Sweden, including fetal growth, gestational age, and presence of a congenital malformation. Poisson regression was used to estimate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for associations between perinatal factors and STS overall, as well as by common subtypes. There were 673 individuals diagnosed with STS in 77.5 million person-years of follow-up. Having a congenital malformation was associated with STS (IRR = 1.70, 95% CI: 1.23–2.35). This association was stronger (IRR = 2.90, 95% CI: 1.25–6.71) in recent years (2000–2012). Low fetal growth was also associated with STS during the same time period (IRR = 1.86, 95% CI: 1.05–3.29). Being born preterm was associated with rhabdomyosarcoma (IRR = 1.74, 95% CI: 1.08–2.79). In our cohort study, those with congenital malformations and other adverse birth outcomes were more likely to develop a STS compared to their unaffected contemporaries. These associations may point to disrupted developmental pathways and genetic factors influencing the risk of STS. 相似文献
57.
Hallet Julie Look Hong Nicole J. Zuk Victoria Davis Laura E. Gupta Vaibhav Earle Craig C. Mittmann Nicole Coburn Natalie G. 《Gastric cancer》2020,23(3):373-381
Gastric Cancer - Esophagogastric cancer (EGC) is one of the deadliest and costliest malignancies to treat. Care by high-volume providers can provide better outcomes for patients with EGC. Cost... 相似文献
58.
Kerryn W. Reding Aaron K. Aragaki Richard K. Cheng Ana Barac Sylvia Wassertheil-Smoller Jessica Chubak Marian C. Limacher W. Gregory Hundley Ralph D'Agostino Jr. Mara Z. Vitolins Theodore M. Brasky Laurel A. Habel Eric J. Chow Rebecca D. Jackson Chu Chen April Morgenroth Wendy E. Barrington Matthew Banegas Matthew Barnhart Rowan T. Chlebowski 《The oncologist》2020,25(8):712-721
59.